Tuesday, September 3, 2013

Does this Free T4 & Free T# make me hypothyroid?

best baby monitor 1.0
 on Wholesale Best price 2.4GHz Wireless Baby Monitor 1.5 Color LCD Night ...
best baby monitor 1.0 image



Milla's Mo


I'm 26 wks pregnant and had hyperthyroid prior to getting pregnant. I've been on PTU from the beginning. Well, now my levels for the past month have been off. My Free T4 is 1.0 and my Free T3 is 267. My OB wants me at the high end of normal and well, I'm obviously not anymore.

Do you think this will have an effect on my unborn twin's brain development? It was at the high normal until I was 5 months pregnant.



Answer
Your free t4 is OK, but your free t3 is on the low side. Supplements like zinc, selenium, and lytrosine help with conversion of T4 into T3, though I have to wonder if you need supplemental T3. I'm hypothyroid, I only feel well if the free t3 is above 350. I think I'd call and talk to mt doctor immediately. It's vry important to have the levels just right when pregnant. I have a friend who miscarried her 2nd pregnancy because she wasn't having her thyroid levels checked every 3-4 weeks. With her 3rd pregnancy, she had levels monitored more often and had a healthy baby girl who is 5 months old now.

Call your doctor or see an endocrinologist who deals with pregnant women.

What if Gardasil?

Q. Do you think Gardasil is a totally safe vaccine? What if in five years from now they find out that the people who have taken the vaccine won't be able to have babies or become pregnant? Should people be taking this risk, since it is a new vaccine? Do you think it is a safe vaccine?


Answer
side effects read and learn plz.


Gardasil
Side Effects & Drug Interactions
font size
A
A
A
SIDE EFFECTS

In 5 clinical trials (4 placebo-controlled), subjects were administered GARDASIL or placebo on the day of enrollment, and approximately 2 and 6 months thereafter. Few subjects (0.1%) discontinued due to adverse experiences. In all except 1 of the clinical trials, safety was evaluated using vaccination report card (VRC)-aided surveillance for 14 days after each injection of GARDASIL or placebo. The subjects who were monitored using VRC-aided surveillance included 5088 girls and women 9 through 26 years of age at enrollment who received GARDASIL and 3790 girls and women who received placebo.

Common Adverse Experiences

Vaccine-related Common Adverse Experiences

The vaccine-related adverse experiences that were observed among female recipients of GARDASIL at a frequency of at least 1.0% and also at a greater frequency than that observed among placebo recipients are shown in Table 6.

Table 6
Vaccine-related Injection-site and Systemic Adverse Experiences*
Adverse Experience
(1 to 5 Days Postvaccination)

GARDASIL
(N = 5088)
%

Aluminum-Containing
Placebo
(N = 3470)
%

Saline
Placebo
(N = 320)
%
Injection Site

Pain

83.9

75.4

48.6
Swelling

25.4

15.8

7.3
Erythema

24.6

18.4

12.1
Pruritus

3.1

2.8

0.6
Adverse Experience
(1 to 15 Days Postvaccination)

GARDASIL
(N = 5088)
%

Placebo
(N = 3790)
%
Systemic

Fever

10.3

8.6

*The vaccine-related adverse experiences that were observed among recipients of GARDASIL were at a frequency of at least 1.0% and also at a greater frequency than that observed among placebo recipients.

All-cause Common Systemic Adverse Experiences

All-cause systemic adverse experiences for female subjects that were observed at a frequency of greater than or equal to 1% where the incidence in the vaccine group was greater than or equal to the incidence in the placebo group are shown in Table 7.

Table 7
All-cause Common Systemic Adverse Experiences
Adverse Experience
(1 to 15 Days Postvaccination)

GARDASIL
(N = 5088)
%

Placebo
(N = 3790)
%
Pyrexia

13.0

11.2
Nausea

6.7

6.6
Nasopharyngitis

6.4

6.4
Dizziness

4.0

3.7
Diarrhea

3.6

3.5
Vomiting

2.4

1.9
Myalgia

2.0

2.0
Cough

2.0

1.5
Toothache

1.5

1.4
Upper respiratory tract infection

1.5

1.5
Malaise

1.4

1.2
Arthralgia

1.2

0.9
Insomnia

1.2

0.9
Nasal congestion

1.1

0.9

Evaluation of Injection-site Adverse Experiences by Dose

An analysis of injection-site adverse experiences in female subjects by dose is shown in Table 8. Overall, 94.3% of subjects who received GARDASIL judged their injection-site adverse experience to be mild or moderate in intensity.


the drug is new answer no...
it has to many side effects
best




Powered by Yahoo! Answers

Title Post: Does this Free T4 & Free T# make me hypothyroid?
Rating: 96% based on 987 ratings. 4,3 user reviews.
Author: Unknown

Thanks For Coming To My Blog

No comments:

Post a Comment